MedTrace Logo

Trial Applying Policy to Eliminate or Reduce Inappropriate Narcotics in the General-population

NCT03400384 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4255

Last updated 2020-09-29

No results posted yet for this study

Summary

To assess the effectiveness of a government-led population-based opioid intervention on discontinuation of opioid medication in community-dwelling adults with chronic non-cancer pain.

Conditions

  • Inappropriate Dose of Drug Administered
  • Pain, Chronic
  • Health Behavior

Interventions

OTHER

Direct-to-consumer educational brochure

The intervention arm will be mailed an evidence-based, theory-driven direct-to-consumer educational brochure, highlighting the potential benefits and harms of opioids when used to treat chronic non-cancer pain.

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal

    lead OTHER

Principal Investigators

  • Cara Tannenbaum, MD, MSc · Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-17
Primary Completion
2019-04-30
Completion
2019-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03400384 on ClinicalTrials.gov